These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24035795)

  • 1. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
    Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
    Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome?
    Campos LM; Omori CH; Lotito AP; Jesus AA; Porta G; Silva CA
    Lupus; 2010 Dec; 19(14):1654-8. PubMed ID: 20837568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe and life-threatening onset of systemic lupus erythematosus.
    Martins A; Pimenta S; Oliveira D; Martins F; Samões B; Costa L
    Reumatol Clin (Engl Ed); 2023; 19(7):402-403. PubMed ID: 37661117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
    Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
    J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
    Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
    Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus.
    Egües Dubuc CA; Uriarte Ecenarro M; Meneses Villalba C; Aldasoro Cáceres V; Hernando Rubio I; Belzunegui Otano J
    Reumatol Clin; 2014; 10(5):321-4. PubMed ID: 24316336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report.
    Fioravante da Silveira L; Zago A; Zanchet D; Chemello D
    Reumatismo; 2023 Jul; 75(2):. PubMed ID: 37462126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Tulbă D; Balea M; Băicuş C
    Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
    Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
    Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
    Jiang N; Li MT; Wu D; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute lupus hemophagocytic syndrome: report of a case.
    Botelho C; Ferrer F; Francisco L; Maia P; Mendes T; Carreira A
    Nefrologia; 2010; 30(2):247-51. PubMed ID: 20038974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).
    Kübler L; Bittmann I; Kuipers JG
    Z Rheumatol; 2020 Dec; 79(10):1040-1045. PubMed ID: 32804304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
    Bennett TD; Fluchel M; Hersh AO; Hayward KN; Hersh AL; Brogan TV; Srivastava R; Stone BL; Korgenski EK; Mundorff MB; Casper TC; Bratton SL
    Arthritis Rheum; 2012 Dec; 64(12):4135-42. PubMed ID: 22886474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
    Aoyama-Maeda N; Horino T; Ichii O; Terada Y
    Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
    Bakshi J; Hassan S; D'Cruz D; Chan A
    Lupus; 2013 Dec; 22(14):1544-6. PubMed ID: 24014570
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.
    Gavand PE; Serio I; Arnaud L; Costedoat-Chalumeau N; Carvelli J; Dossier A; Hinschberger O; Mouthon L; Le Guern V; Korganow AS; Poindron V; Gourguechon C; Lavigne C; Maurier F; Labro G; Heymonet M; Artifoni M; Viau AB; Deligny C; Sene T; Terriou L; Sibilia J; Mathian A; Bloch-Queyrat C; Larroche C; Amoura Z; Martin T
    Autoimmun Rev; 2017 Jul; 16(7):743-749. PubMed ID: 28483541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
    Junga Z; Stitt R; Tracy C; Keith M
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28827301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemophagocytic Syndrome: a clinical presentation of systemic lupus erythematosus].
    Silva Dda F; Anunciação FA; Arcoverde Jda C; Costa LP; Marques ID; Pinheiro Gda S; Moreira Mdo S
    Acta Reumatol Port; 2008; 33(1):91-7. PubMed ID: 18344927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of macrophage activation syndrome in children with rheumatic disorders.
    Moradinejad MH; Ziaee V
    Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
    Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
    Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.